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Surgical Pulmonary Resection of Recurred Non-Small Cell Lung 
Cancer After Prior Lobectomy
Lee, Yong Jik; Kim, Dong Kwan; Park, Seung Il; Kim, Yong Hee; 
Kang, Pil Je; Lee, Hyun Joo; Chun, Mi Sun 
Asan Medical Center, Seoul, Korea
Background: Surgical resection is the most effective treatment for 
patients with non-small cell lung cancer, but the effects of surgery in 
recurrent lung cancer is not well-established. The objective of this 
study was to evaluate the safety and efﬁcacy of surgical resection for 
recurrent lung cancer after prior lobectomy.
Methods: Between January 1992 and March 2006, 1892 patients with 
primary lung carcinoma underwent surgical resection. Among these 
patients, 262 were diagnosed with recurrent lung carcinoma for which 
surgical resection was performed for 28 patients. A total of 6 patients 
diagnosed with metachronous cancer were excluded. Type of resection, 
postoperative morbidity and mortality, and factors inﬂuencing survival 
were analyzed.
Results: Twenty-ﬁve resections were performed in 22 patients after pri-
or lobectomy. All patients were diagnosed with pulmonary metastasis. 
Completion pneumonectomy was performed in six patients, lobectomy 
in 5, segmentectomy or wedge resection in 14 patients. Median follow 
up duration was 33.7 months. Two patients were treated with BPF after 
a second operation. There was no 30-day mortality, the median survival 
was 38.0 months and the overall 1-, 3-year survival rate was 71.7%, 
54.6%, respectively. Median survival was 11.6 months in those with 
short disease free interval (less than 1 year) and 40.6 months in those 
with more than 1 year disease free interval (p<0.05).
Conclusions: Surgical resection of recurrent lung cancer resulted in 
survival similar to those of primary lung cancer. Multimodality treat-
ment including surgical resection should be considered in those patients 
with postoperative recurrent non-small cell lung cancer.
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Lung volume reduction surgery in lung cancer resection
Lequaglie, Cosimo; Giudice, Gabriella; Della Morte, Aniello 
Centro Riferimento Oncologico Regionale, Rionero in Vulture PZ, Italy
Background: We report two new surgical techniques in emphysema-
tous with concurrent resectable lung cancer to reduce hospital stay and 
improve quality of life.
Methods: Between January 2005 and June 2006 we performed 45 lung 
volume reductions to as many ipsilateral major resections. Forty-one 
patients (mean age: 65 ± 7 years) had primary NSCLCs and 4 colorectal 
metastases. FEV1 baseline was 0.90 ± 0.3 L and RV was 5.1 ± 0.7 L.
The bullectomy was separated from cancer resection in 11 cases: 8 
lobectomies, 1 bilobectomy and 2 wedge resections for metastases. We 
performed in partnership stapler to the stratum of collagen for the bul-
lectomy, both for open surgery than for videothoracoscopy.
The intraparenchimal caverns were approached in 32 lobectomies and 2 
bilobectomies through a short muscle sparing thoracotomy and opened 
after disinfection. First the ﬁbrin glue was instilled and manufactured 
a patch with stratum of collagen to close the bulla without tailoring. 
The manoeuvre can be performed also with an elastic synthetic sealant, 
always combining it to the usual stratum of collagen.
Results: There were only 4 postoperative transient cardiac arrhythmias. 
Median hospital stay was 6 days (range: 5-14). The postoperative lung 
function did not have an unfavourable result (26% improved preopera-
tive FEV1). The two procedures were without a ﬁnal increase of the 
costs of management neither for duration neither for the postoperative 
hospitalization. In fact, to forehead of few about 10.00 € the cure of 
the bulla/caverna can be performed strengthening the mechanical suture 
with reabsorbable material as the patches of collagen and maintaining 
the initial elasticity of the pulmonary parenchima to term application.
Conclusions: The costs of the described methods are reduced and 
lower to any other employee for such pathologies with excellent results 
in the care of the same diseases.
The careful employment of adhesive, sealant and biomatherials has 
generally modiﬁed surgical procedures already consolidated even if 
sometimes not enough to the pathologies to be treated and it has wid-
ened the indications of it allowing what ﬁrst with difﬁculty or technical 
artiﬁces today it can be simpliﬁed.
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Synchronous lung cancers
Li, Hui; Hou, Shengcai; Hu, Bin 
Dept. of Thoracic Surgery, Beijing Chaoyang Hospital, Capital Medical 
University, Beijing, China
Objective: Synchronous lung cancer is the simultaneous presence of 
more than one primary foci of cancer in separate anatomical compo-
nents of the lung. In order to assess the incidence of synchronous lung 
cancers, as well as the clinical features and surgical results of this con-
dition, we retrospectively analyzed 1019 consecutive patients admitted 
to our hospital with carcinoma of the lung. 
Methods: During a 10-year period (1990-1999) synchronous multiple 
primary lung cancers were treated surgically in 5 patients. The data 
were retrospectively analyzed. 
Results: Five patients (0.5%) had synchronous multiple primary lung 
cancers of all 1019 patients with primary carcinoma of the lung. The 
mean age of 5 patients was 62.5 years old, and all of those were male. 
Three synchronous tumors were ipsilateral and two were bilateral. Five 
patients underwent resection of both tumors. Three synchronous tumors 
were ipsilateral and treated with one pneumonectomy, one lobectomies 
and one double wedge resection. The bilateral synchronous lesions (2 
patients) were treated by staged bilateral thoracotomy (mean interval; 
2 months). The ﬁrst resection consisted of a lobectomy in one patient 
and wedge resection in one. The second one was a wedge resection 
in two patients. There was no operative death. Postoperative course 
was uneventful.The 2- and 5-year survival rates were 41% and 12.2%, 
respectively. The stage I synchronous lung cancers had better survival 
than the stage II patients.
Conclusion: Surgeons should be aware of the possibility of multiple 
primary cancers. The diagnostic procedures and tumor stage should 
be done separately for each lesions in patients who had more than one 
lesion. One stage surgery was recommeded for ipsilateral synchronous 
lung cancers and for bilateral synchronous cancers, staged bilateral 
thoracotomies or double wedge resection at an interval could obtain 
satisfactory results.
